Dr. Srivastava Rakesh
Dr Rakesh is an accomplished entrepreneur and is the CEO and President of GLAX Health LLC.
WILMINGTON, DELAWARE, UNITED STATES, August 23, 2022
In layman's terms, inflammation is when your immune system responds to an irritant. An irritant could be anything from pathogens in your body or a foreign object such as a splinter. However, the body could produce inflammatory cells without an irritant or injury, leading to chronic inflammation. Keep reading this article to learn more about inflammation and Dr. Rakesh Srivastava's journey to developing a new anti-inflammatory drug for human diseases.
Causes of inflammation
According to Dr. Rakesh, the most common causes of inflammation include external injuries, lingering effects of radiation or chemicals, and germs. Autoimmune disorders or medical conditions such as dermatitis, bronchitis, cystitis, or otitis media could cause inflammation.
Signs of inflammation
Below are the four main signs of inflammation you should know.
· Heat
· Pain
· Redness
· Loss of function
· Swelling
It is important to note that not all inflammations manifest in the signs we have mentioned above. Your body might experience a silent inflammation without you knowing.
Anti-inflammatory drugs that target COX-2
Cyclooxygenase, also known as COX-2, is responsible for generating arachidonic acid metabolite. COX-2 is also the main enzyme involved in arachidonic acid metabolism. Since COX-2 is connected to numerous human diseases, scientists believe that developing a drug targeting this enzyme is the key to eradicating human diseases. However, research reveals that the effect of anti-inflammatory drugs on COX-2 causes unpleasant side effects on the body, such as neuro and cardiotoxicity. Fortunately, Dr. Rakesh K. Srivastava has formulated a drug that limits these toxic side effects while inhibiting the problematic COX-2 enzyme. He firmly believes his newfound discovery could be the key to treating diseases like cancer, type 1 and 2 diabetes mellitus, endometriosis, and rheumatoid arthritis, among others.
Dr. Srivastava's biography
Dr. Rakesh K. Srivastava has always had a hunger for knowledge and has dedicated his life to doing research, teaching, and service to others. His fiery passion and dedication to his work leave us in awe, and he is a true inspiration to everyone who would like to pursue a career in academia. After he attained his Ph.D. from the University Of Guelph, Ontario, he proceeded to attend a fellowship at the US National Academy of Sciences. His work as a Senior Scientist and Endowed Professor at various universities and research centers adds to his numerous achievements.
After many years of learning and expanding his knowledge base, Dr. Srivastava is now the CEO and President of GLAX Health, a biotechnology company dedicated to researching and developing new drugs for diseases that affect humans today. For over 30 years, Dr. Rakesh has specialized in obesity, virology, therapeutics, cell signaling, and nutrition. He is working with his able team to develop a vaccine for the deadly Coronavirus.
Despite his academic prowess, Dr. Rakesh K. Srivastava creates time to nurture his hobbies and decompress. Some activities he enjoys indulging in during his free time include traveling, reading, fishing, photography, and exploration.
We hope this article has helped you learn more about inflammation and given insight into Dr. Rakesh K. Srivastava's efforts to improve the quality of life for people with chronic diseases.
YOU ARE READING
The Discovery of Anti-Inflammatory Drugs for Human Diseases
Non-FictionRead this article to learn more about inflammation and Dr. Rakesh Srivastava's journey to developing a new anti-inflammatory drug for human diseases.